Head and Neck Adenocarcinoma — Trials

Head and Neck Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 19
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 201–213 of 213 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01354639	Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open Thyroidectomy	completed	—	150	Yonsei UniversityOTHER	1	Feb 5, 2014	clinicaltrials
NCT00095693	Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer	terminated	Phase 2	25	National Cancer Institute (NCI)NIH	1	Jan 16, 2014	clinicaltrials